To Enrich Big Pharma, FDA and DEA Deny Science on Medical Marijuana
It would be unreasonable, arbitrary and capricious for DEA to stand between sufferers and the benefits of this substance in light of the evidence.
It would be unreasonable, arbitrary and capricious for DEA to stand between sufferers and the benefits of this substance in light of the evidence.